General Biologicals Corporation (TPEX:4117)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.15
-0.15 (-1.22%)
Feb 11, 2026, 2:59 PM CST

General Biologicals Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
195.76251.65217.12262.18308.77350.61
Short-Term Investments
---88.960122.99
Cash & Short-Term Investments
195.76251.65217.12351.08368.77473.6
Cash Growth
-9.65%15.90%-38.16%-4.80%-22.13%2001.14%
Accounts Receivable
55.1296.6984.3657.1842.3157.61
Other Receivables
44.651.090.724.325.171.3
Receivables
99.7897.7885.0961.547.4958.91
Inventory
71.8957.0885.56116.7981.3264.86
Prepaid Expenses
64.51--18.3311.56-
Other Current Assets
4.9840.1114.093.281.1811.55
Total Current Assets
436.92446.61401.85550.97510.32608.91
Property, Plant & Equipment
844.372,8192,002864.46607.87126.1
Long-Term Investments
30.8140.4538.1636.6838.529.8
Goodwill
21.6121.6120.6820.6820.6844.05
Other Intangible Assets
30.932.7136.1941.0944.5818.53
Long-Term Deferred Tax Assets
---11.9318.9113.8
Other Long-Term Assets
2,17545.1637.9624.7723.5812.1
Total Assets
3,5403,4062,5371,5511,264833.28
Accounts Payable
62.3682.7224.2625.338.7440.39
Accrued Expenses
14.0715.1118.5112.212.9512.56
Short-Term Debt
6060505--
Current Portion of Long-Term Debt
65.1441.041.591.573.247.33
Current Portion of Leases
10.59107.67117.7310.17.756.61
Current Unearned Revenue
89.9695.366.485.823.837.16
Other Current Liabilities
28.1248.89810.7338.0510.5611.33
Total Current Liabilities
330.24450.791,02998.0477.0785.37
Long-Term Debt
1,9821,69733.540.131.711.67
Long-Term Leases
396.55404.2345.6452.02436.7449.14
Long-Term Unearned Revenue
607.88556.26620.7---
Pension & Post-Retirement Benefits
---0.020.950.79
Long-Term Deferred Tax Liabilities
4.464.64.96.195.48-
Other Long-Term Liabilities
62.186.656.65301.117.848.57
Total Liabilities
3,3833,1192,041857.51529.79145.54
Common Stock
608.25608.25598.25598.25598.25598.25
Additional Paid-In Capital
99.2899.2887.887.887.8404.16
Retained Earnings
-557.19-428.4-207.03-8.2344.05-316.36
Comprehensive Income & Other
5.915.4616.1212.711.42-1.5
Total Common Equity
156.24284.59495.13690.52731.51684.55
Minority Interest
0.661.91.512.553.143.2
Shareholders' Equity
156.9286.48496.65693.07734.66687.74
Total Liabilities & Equity
3,5403,4062,5371,5511,264833.28
Total Debt
2,5142,310548.46468.82449.4464.75
Net Cash (Debt)
-2,318-2,058-331.34-117.74-80.66408.85
Net Cash Per Share
-38.75-34.40-5.54-1.97-1.357.74
Filing Date Shares Outstanding
60.8360.8359.8359.8359.8359.83
Total Common Shares Outstanding
60.8360.8359.8359.8359.8359.83
Working Capital
106.69-4.19-627.45452.94433.25523.54
Book Value Per Share
2.574.688.2811.5412.2311.44
Tangible Book Value
103.73230.26438.27628.76666.26621.96
Tangible Book Value Per Share
1.713.797.3310.5111.1410.40
Buildings
472.9850.0250.0249.8549.8650.81
Machinery
195.37194.1189.38174.16171.07168.63
Construction In Progress
197.372,2101,415263.911.77-
Leasehold Improvements
20.1320.1320.1320.1320.1320.61
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.